JPWO2019207257A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019207257A5
JPWO2019207257A5 JP2020559423A JP2020559423A JPWO2019207257A5 JP WO2019207257 A5 JPWO2019207257 A5 JP WO2019207257A5 JP 2020559423 A JP2020559423 A JP 2020559423A JP 2020559423 A JP2020559423 A JP 2020559423A JP WO2019207257 A5 JPWO2019207257 A5 JP WO2019207257A5
Authority
JP
Japan
Prior art keywords
group
alkyl group
compound
atom
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020559423A
Other languages
English (en)
Japanese (ja)
Other versions
JP7408894B2 (ja
JP2021522244A5 (https=
JP2021522244A (ja
Publication date
Priority claimed from FR1853709A external-priority patent/FR3080620B1/fr
Application filed filed Critical
Publication of JP2021522244A publication Critical patent/JP2021522244A/ja
Publication of JP2021522244A5 publication Critical patent/JP2021522244A5/ja
Publication of JPWO2019207257A5 publication Critical patent/JPWO2019207257A5/ja
Application granted granted Critical
Publication of JP7408894B2 publication Critical patent/JP7408894B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020559423A 2018-04-27 2019-04-26 チューブリン重合阻害活性及び免疫調節特性を有する化合物 Active JP7408894B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1853709A FR3080620B1 (fr) 2018-04-27 2018-04-27 Composes a activite inhibitrice de la polymerisation de la tubuline et aux proprietes immunomodulatrices
FR1853709 2018-04-27
PCT/FR2019/050982 WO2019207257A1 (fr) 2018-04-27 2019-04-26 Composes a activite inhibitrice de la polymerisation de la tubuline et aux proprietes immunomodulatrices

Publications (4)

Publication Number Publication Date
JP2021522244A JP2021522244A (ja) 2021-08-30
JP2021522244A5 JP2021522244A5 (https=) 2022-05-02
JPWO2019207257A5 true JPWO2019207257A5 (https=) 2022-05-02
JP7408894B2 JP7408894B2 (ja) 2024-01-09

Family

ID=63036097

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020559423A Active JP7408894B2 (ja) 2018-04-27 2019-04-26 チューブリン重合阻害活性及び免疫調節特性を有する化合物

Country Status (9)

Country Link
US (2) US11634405B2 (https=)
EP (1) EP3784662B1 (https=)
JP (1) JP7408894B2 (https=)
AU (1) AU2019259112B2 (https=)
CA (1) CA3097622A1 (https=)
DK (1) DK3784662T3 (https=)
ES (1) ES2932370T3 (https=)
FR (1) FR3080620B1 (https=)
WO (1) WO2019207257A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111825610B (zh) * 2020-06-24 2023-03-31 中国药科大学 一种具有抗肿瘤活性的2-甲基喹啉类衍生物及其合成方法和用途
CN115417860B (zh) * 2020-08-03 2023-10-20 中国药科大学 一种具有抗肿瘤活性的喹唑啉类衍生物及其合成方法和用途
CN113173915B (zh) * 2021-03-29 2022-12-09 中南大学湘雅医院 抗皮肤肿瘤化合物及其应用
CN113620874B (zh) * 2021-08-10 2024-02-06 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 2-三氟甲基-4-氨基-喹啉衍生物及其用途
CN114436975B (zh) * 2022-01-26 2023-10-31 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 2-三氟甲基-4-氨基喹唑啉类化合物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323290D0 (en) * 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
GB9514265D0 (en) * 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
SK288365B6 (sk) * 1999-02-10 2016-07-01 Astrazeneca Ab Medziprodukty pre chinazolínové deriváty ako inhibítory angiogenézy
JP2003535867A (ja) 2000-06-06 2003-12-02 ファイザー プロダクツ インコーポレイテッド 抗癌剤として有用なチオフェン誘導体
GB0126433D0 (en) 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
AU2004289303A1 (en) * 2003-11-10 2005-05-26 Synta Pharmaceuticals, Corp. Fused heterocyclic compounds
EA009994B1 (ru) * 2003-12-23 2008-06-30 Пфайзер Инк. Новые хинолиновые производные
KR20070117547A (ko) 2005-01-03 2007-12-12 미리어드 제네틱스, 인크. 뇌암 치료방법
GB0508717D0 (en) 2005-04-29 2005-06-08 Astrazeneca Ab Chemical compounds
JP2009508917A (ja) * 2005-09-20 2009-03-05 アストラゼネカ アクチボラグ 抗癌剤としてのキナゾリン誘導体
FR2914640B1 (fr) 2007-04-04 2012-11-16 Centre Nat Rech Scient Iso ca-4 et analogues : puissants cytotoxiques, inhibiteurs de polymerisation de la tubuline

Similar Documents

Publication Publication Date Title
JP2021522244A5 (https=)
JP2024100974A5 (https=)
JP2006507355A5 (https=)
JP2014513704A5 (https=)
JP2006508903A5 (https=)
JP2016518437A5 (https=)
JP2021522262A5 (https=)
JP2013530142A5 (https=)
JP2007503388A5 (https=)
JP2011523952A5 (https=)
JP2020128426A5 (https=)
JP2009536221A5 (https=)
JPWO2023106310A5 (https=)
JP2020063289A5 (https=)
JP2007502295A5 (https=)
JPWO2021108628A5 (https=)
JPWO2019207257A5 (https=)
JP2008518900A5 (https=)
JP2017513852A5 (https=)
JPWO2023275366A5 (https=)
JPWO2019183226A5 (https=)
JP2013544880A5 (https=)
JP2009514955A5 (https=)
JPWO2023072240A5 (https=)
JPWO2023072257A5 (https=)